Epidemiology of Alcohol Misuse and Illicit Drug Use Among Young People Aged 15-24 Years in Fishing Communities in Uganda.
Sub-Saharan Africa
adolescents
alcohol
drugs
fisherfolk
substance use
survey
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
01 04 2020
01 04 2020
Historique:
received:
11
03
2020
revised:
29
03
2020
accepted:
30
03
2020
entrez:
5
4
2020
pubmed:
5
4
2020
medline:
22
10
2020
Statut:
epublish
Résumé
We determined the prevalence of and risk factors for alcohol misuse and illicit drug use among young Ugandans in fishing communities, a recognised "key population" for human immunodeficiency virus (HIV) infection. We conducted a cross-sectional survey among young people (15-24 years) in fishing communities in Koome, Uganda, in December 2017-July 2018. Using Audio-Assisted Self-Interviewing, we collected data on socio-demographic characteristics and alcohol use, including the Alcohol Use Disorders Identification Test (AUDIT) and timeline follow-back calendar (TLFB). Blood samples were analysed for HIV, herpes simplex virus 2 (HSV2), and Phosphatidyl ethanol (PEth 16:0/18:1). Urine samples were analysed for illicit drugs. Among 1281 participants (52.7% male, mean age 20 years), 659 (51.4%) reported ever drinking alcohol, 248 (19.4%) had 12-month-AUDIT ≥ 8, and 261 (20.5%) had whole-blood PEth 16:0/18:1 concentration ≥ 20 ng/mL, indicating significant consumption. In multivariable analyses, PEth 16:0/18:1 ≥ 20ng/mL, AUDIT ≥ 8 and binge drinking (≥6 standard drinks per drinking occasion in the previous month from TLFB) were all strongly associated with older age, low education, smoking, and HSV2. Illicit drug use prevalence was 5.2% and was associated with older age, low education, being single, and smoking. Levels of alcohol misuse were high among young people in fishing communities and associated with HSV2, a proxy for risky sexual behaviour. Alcohol and illicit drug harm reduction services and HIV prevention programs in Uganda should prioritise young fisherfolk.
Sections du résumé
BACKGROUND
We determined the prevalence of and risk factors for alcohol misuse and illicit drug use among young Ugandans in fishing communities, a recognised "key population" for human immunodeficiency virus (HIV) infection.
METHODS
We conducted a cross-sectional survey among young people (15-24 years) in fishing communities in Koome, Uganda, in December 2017-July 2018. Using Audio-Assisted Self-Interviewing, we collected data on socio-demographic characteristics and alcohol use, including the Alcohol Use Disorders Identification Test (AUDIT) and timeline follow-back calendar (TLFB). Blood samples were analysed for HIV, herpes simplex virus 2 (HSV2), and Phosphatidyl ethanol (PEth 16:0/18:1). Urine samples were analysed for illicit drugs.
RESULTS
Among 1281 participants (52.7% male, mean age 20 years), 659 (51.4%) reported ever drinking alcohol, 248 (19.4%) had 12-month-AUDIT ≥ 8, and 261 (20.5%) had whole-blood PEth 16:0/18:1 concentration ≥ 20 ng/mL, indicating significant consumption. In multivariable analyses, PEth 16:0/18:1 ≥ 20ng/mL, AUDIT ≥ 8 and binge drinking (≥6 standard drinks per drinking occasion in the previous month from TLFB) were all strongly associated with older age, low education, smoking, and HSV2. Illicit drug use prevalence was 5.2% and was associated with older age, low education, being single, and smoking.
CONCLUSION
Levels of alcohol misuse were high among young people in fishing communities and associated with HSV2, a proxy for risky sexual behaviour. Alcohol and illicit drug harm reduction services and HIV prevention programs in Uganda should prioritise young fisherfolk.
Identifiants
pubmed: 32244722
pii: ijerph17072401
doi: 10.3390/ijerph17072401
pmc: PMC7178227
pii:
doi:
Substances chimiques
Illicit Drugs
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medical Research Council
ID : MR/K012126/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R010161/1
Pays : United Kingdom
Références
AIDS. 2018 Jul 17;32(11):1507-1515
pubmed: 29734218
Harm Reduct J. 2009 Aug 28;6:24
pubmed: 19715601
AIDS Care. 2014;26(3):282-91
pubmed: 23941609
Lancet Psychiatry. 2016 Mar;3(3):251-64
pubmed: 26905480
Int J Mol Sci. 2012 Nov 13;13(11):14788-812
pubmed: 23203094
PLoS One. 2017 Feb 16;12(2):e0171200
pubmed: 28207844
Clin Chem. 2009 Jul;55(7):1395-405
pubmed: 19423735
Sex Transm Dis. 2012 Jun;39(6):433-9
pubmed: 22592828
BMC Public Health. 2014 Nov 22;14:1202
pubmed: 25416140
Trop Med Int Health. 2014 Apr;19(4):476-88
pubmed: 24479379
Lancet Psychiatry. 2016 Mar;3(3):265-79
pubmed: 26905482
PLoS One. 2014 May 27;9(5):e94932
pubmed: 24866840
Addict Biol. 2010 Jan;15(1):88-95
pubmed: 20002024
Lancet. 2017 Feb 11;389(10069):589-590
pubmed: 28195048
Am J Psychiatry. 2013 Aug;170(8):834-51
pubmed: 23903334
AIDS Behav. 2016 Mar;20(3):537-47
pubmed: 25921303
Alcohol Res Health. 2010;33(3):203-18
pubmed: 23584062
Int J Epidemiol. 1997 Feb;26(1):224-7
pubmed: 9126524
Am J Epidemiol. 2006 Feb 1;163(3):197-203
pubmed: 16339049
BMC Infect Dis. 2017 Jan 19;17(1):88
pubmed: 28103834
Addict Behav. 2010 Dec;35(12):1144-7
pubmed: 20719435
Trop Med Int Health. 2015 Sep;20(9):1201-1208
pubmed: 25976017
Clin Infect Dis. 2019 May 2;68(10):1665-1674
pubmed: 30202872
PLoS One. 2015 Oct 07;10(10):e0140041
pubmed: 26444441
Alcohol Clin Exp Res. 2010 Aug;34(8):1400-8
pubmed: 20491737
Int J Environ Res Public Health. 2016 Jan 22;13(2):153
pubmed: 26805868
J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):180-202
pubmed: 19668086
PLoS One. 2013;8(1):e54523
pubmed: 23336005
Alcohol Clin Exp Res. 2012 May;36(5):854-62
pubmed: 22150449
Lancet Infect Dis. 2017 Dec;17(12):1303-1316
pubmed: 28843576
Addiction. 2002 Sep;97(9):1183-94
pubmed: 12199834
AIDS Behav. 2019 Dec;23(12):3199-3225
pubmed: 30945031
Lakartidningen. 2013 Sep 25-Oct 8;110(39-40):1747-8
pubmed: 24245431
Lancet Glob Health. 2017 Dec;5(12):e1192-e1207
pubmed: 29074409
BMC Public Health. 2012 Dec 11;12:1069
pubmed: 23231779
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941